A Study to Assess Pharmacokinetics and Pharmacodynamics Following Administration of BAY1093884 in Patients With Severe Hemophilia

NCT03481946 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A; Hemophilia B

Interventions

DRUG: BAY1093884
DRUG: BAY1093884

Sponsor

Bayer